Geode Capital Management’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.1K | Sell |
|
|||||
|
2025
Q1 | $21.5K | Sell |
|
|||||
|
2024
Q4 | $75.3K | Hold |
|
|||||
|
2024
Q3 | $133K | Buy |
|
|||||
|
2024
Q2 | $115K | Hold |
|
|||||
|
2024
Q1 | $186K | Hold |
|
|||||
|
2023
Q4 | $93.5K | Hold |
|
|||||
|
2023
Q3 | $92K | Hold |
|
|||||
|
2023
Q2 | $109K | Buy |
|
|||||
|
2023
Q1 | $115K | Hold |
|
|||||
|
2022
Q4 | $154K | Buy |
|
|||||
|
2022
Q3 | $78K | Hold |
|
|||||
|
2022
Q2 | $123K | Hold |
|
|||||
|
2022
Q1 | $149K | Hold |
|
|||||
|
2021
Q4 | $272K | Hold |
|
|||||
|
2021
Q3 | $376K | Hold |
|
|||||
|
2021
Q2 | $309K | Hold |
|
|||||
|
2021
Q1 | $386K | Buy |
|
|||||
|
2020
Q4 | $265K | Sell |
|
|||||
|
2020
Q3 | $883K | Buy |
|
|||||
|
2020
Q2 | $610K | Buy |
|
|||||
|
2020
Q1 | $139K | Sell |
|
|||||
|
2019
Q4 | $117K | Buy |
|
|||||
|
2019
Q3 | $96K | Hold |
|
|||||
|
2019
Q2 | $257K | Hold |
|
|||||
|
2019
Q1 | $275K | Buy |
|
|||||
|
2018
Q4 | $225K | Sell |
|
|||||
|
2018
Q3 | $537K | Sell |
|
|||||
|
2018
Q2 | $487K | Sell |
|
|||||
|
2018
Q1 | $485K | Buy |
|
|||||
|
2017
Q4 | $191K | Buy |
|
|||||
|
2017
Q3 | $234K | Hold |
|
|||||
|
2017
Q2 | $128K | Buy |
|
|||||
|
2017
Q1 | $92K | Buy |
|
|||||
|
2016
Q4 | $66K | Buy |
|
|||||
|
2016
Q3 | $113K | Buy |
|
|||||
|
2016
Q2 | $83K | Buy |
|